The neuroactive potential of the human gut microbiota in quality of life and depression

Nature Microbiology

Volumn 4, Issue 4, 2019, Pages 623-632

  Valles Colomer, Mireia ^a,b   Falony, Gwen ^a,b   Darzi, Youssef ^a,b   Tigchelaar, Ettje F ^c   Wang, Jun ^a,b   Tito, Raul Y ^a,b,d   Schiweck, Carmen ^e   Kurilshikov, Alexander ^c   Joossens, Marie ^a,b   Wijmenga, Cisca ^c,f   Claes, Stephan ^e,g   Van Oudenhove, Lukas ^g,h   Zhernakova, Alexandra ^c   Vieira Silva, Sara ^a,b   Raes, Jeroen ^a,b  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^e KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY OF OSLO   (Norway)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE;

ADULT; ARTICLE; BACTERIAL MICROBIOME; BACTEROIDES; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; COPROCOCCUS; DEPRESSION; DRUG EFFECT; FAECALIBACTERIUM; FEMALE; FIRMICUTES; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METAGENOMICS; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; SPECIES COMPOSITION; BACTERIUM; CLASSIFICATION; FECES; GENETICS; INTESTINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PSYCHOLOGY;

3,4-DIHYDROXYPHENYLACETIC ACID; ADULT; BACTERIA; COHORT STUDIES; DEPRESSION; DOPAMINE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 85061191066     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/s41564-018-0337-x     Document Type: Article

References (82)

1. Cryan, J. F. & Dinan, T. G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13, 701–712 (2012).
2. O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G. & Cryan, J. F. Serotonin, tryptophan metabolism and the brain–gut–microbiome axis. Behav. Brain. Res. 277, 32–48 (2015).
3. Braniste, V. et al. The gut microbiota influences blood–brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158 (2014).
4. Lyte, M. & Brown, D. R. Evidence for PMAT- and OCT-like biogenic amine transporters in a probiotic strain of Lactobacillus: implications for interkingdom communication within the microbiota–gut–brain axis. PLoS ONE 13, e0191037 (2018).
5. Mcdonald, D. et al. American Gut: an open platform for citizen science. mSystems 3, e00031-18 (2018).
6. Naseribafrouei, A. et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol. Motil. 26, 1155–1162 (2014).
7. Jiang, H. et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun. 48, 186–194 (2015).
8. Zheng, P. et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol. Psychiatry 21, 786–796 (2016).
9. Kelly, J. R. et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J. Psychiatr. Res. 82, 109–118 (2016).
10. Hill, J. M., Clement, C., Pogue, A. I., Bhattacharjee, S. & Zhao, Y. et al. Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Front. Aging Neurosci. 6, 127 (2014).
11. Burokas, A., Moloney, R. D., Dinan, T. G. & Cryan, J. F. Microbiota regulation of the mammalian gut–brain axis. 91, 1–62 (2015).
12. Falony, G., Vieira-Silva, S. & Raes, J. Richness and ecosystem development across faecal snapshots of the gut microbiota. Nat. Microbiol. 3, 526–528 (2018).
13. Kelly, J. R. et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav. Immun. 61, 50–59 (2017).
14. Bedarf, J. R. et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients. Genome Med. 9, 39 (2017).
15. Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016).
16. Zhernakova, A. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
17. Tigchelaar, E. F. et al. Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 5, e006772 (2015).
18. Hays, R. D., Sherbourne, C. D. & Mazel, R. M. The RAND 36-Item Health Survey 1.0. Health Econ. 2, 217–227 (1993).
19. Hays, R. D. & Morales, L. S. The RAND-36 measure of health-related quality of life. Ann. Med. 33, 350–357 (2001).
20. Ware, J. E., Keller, S. D. & Kosinski, M. SF-36: Physical and Mental Health Summary Scales (Health Institute, New England Medical Center, Boston, 1994).
21. Lewis, S. J. & Heaton, K. W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 32, 920–924 (1997).
22. Rivière, A., Selak, M., Lantin, D., Leroy, F. & De Vuyst, L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front. Microbiol. 7, 979 (2016).
23. Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014).
24. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).
25. Li, L. et al. Gut microbes in correlation with mood: case study in a closed experimental human life support system. Neurogastroenterol. Motil. 28, 1233–1240 (2016).
26. Watten, R. G., Syversen, J. L. & Myhrer, T. Quality of life, intelligence and mood. Soc. Indic. Res. 36, 287–299 (1995).
27. National Collaborating Centre for Mental Health, National Institute for Health and Clinical Excellence, Royal College of Psychiatrists, British Psychological Society Depression: the Treatment and Management of Depression in Adults (British Psychological Society and Royal College of Psychiatrists, London, 2010).
28. Bruffaerts, R., Bonnewyn, A. & Demyttenaere, K. The epidemiology of depression in Belgium. A review and some reflections for the future [Article in Dutch]. Tijdschr. Psychiatr. 50, 655–665 (2008).
29. Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
30. Cussotto, S. et al. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology 10.1007/s00213-018-5006-5 (2018).
31. Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).
32. Dinan, T. G., Stanton, C. & Cryan, J. F. Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 74, 720–726 (2013).
33. Holmes, I., Harris, K. & Quince, C. Dirichlet multinomial mixtures: generative models for microbialmetagenomics. PLoS ONE 7, e30126 (2012).
34. Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017).
35. Markowitz, V. M. et al. IMG 4 version of the integrated microbial genomes comparative analysis system. Nucleic Acids Res. 42, D560–D567 (2014).
36. Lyte, M. & Ernst, S. Catecholamine induced growth of gram negative bacteria. Life Sci. 50, 203–212 (1992).
37. McLean, P. G., Borman, R. A. & Lee, K. 5-HT in the enteric nervous system: gut function and neuropharmacology. Trends Neurosci. 30, 9–13 (2007).
38. Yano, J. M. et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264–276 (2015).
39. Tsavkelova, E. A., Klimova, S. Y., Cherdyntseva, T. A. & Netrusov, A. I. Hormones and hormone-like substances of microorganisms: a review [Article in Russian]. Prikl. Biokhim. Mikrobiol. 42, 261–268 (2006).
40. Lyte, M. & Cryan, J. F. (eds) Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health (Springer, New York, 2014).
41. Mazzoli, R. & Pessione, E. The neuro-endocrinological role of microbial glutamate and GABA signaling. Front. Microbiol. 7, 1934 (2016).
42. Feehily, C., O’Byrne, C. P. & Karatzas, K. A. G. Functional γ-aminobutyrate shunt in Listeria monocytogenes: role in acid tolerance and succinate biosynthesis. Appl. Environ. Microbiol. 79, 74–80 (2013).
43. Nogueira, T. et al. Horizontal gene transfer of the secretome drives the evolution of bacterial cooperation and virulence. Curr. Biol. 19, 1683–1691 (2009).
44. Gao, K. et al. Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr. 136, 52–57 (2006).
45. Goldstein, D. S., Holmes, C., Lopez, G. J., Wu, T. & Sharabi, Y. Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson’s disease. Parkinsonism Relat. Disord. 50, 108–112 (2018).
46. Bienenstock, J., Forsythe, P., Karimi, K. & Kunze, W. Neuroimmune aspects of food intake. Int. Dairy J. 20, 253–258 (2010).
47. Petty, F. Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin. Chem. 40, 296–302 (1994).
48. Inoshita, M. et al. Elevated peripheral blood glutamate levels in major depressive disorder. Neuropsychiatr. Dis. Treat. 14, 945–953 (2018).
49. Chow, S., Shao, J. & Wang, H. Sample Size Calculations in Clinical Trial Research (Chapman and Hall, Boca Raton, 2008).
50. Aaronson, N. K. et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J. Clin. Epidemiol. 51, 1055–1068 (1998).
51. WHO Collaborating Centre for Drug Statistics Methodology ATC Classification Index with DDDs (WHO, 2017).
52. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: Text Revision 4th edn (American Psychiatric Association, Washington, 2002).
53. Mujagic, Z. et al. A novel biomarker panel for irritable bowel syndrome and the application in the general population. Sci. Rep. 6, 26420 (2016).
54. Tito, R. Y. et al. Brief report: D ialister as a microbial marker of disease activity in spondyloarthritis. Arthritis Rheumatol. 69, 114–121 (2017).
55. Hildebrand, F., Tadeo, R., Voigt, A. Y., Bork, P. & Raes, J. LotuS: an efficient and user-friendly OTU processing pipeline. Microbiome 2, 30 (2014).
56. Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
57. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261–5267 (2007).
58. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
59. Schmieder, R. & Edwards, R. Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PLoS ONE 6, e17288 (2011).
60. Cock, P. J. A. et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 25, 1422–1423 (2009).
61. Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834–841 (2014).
62. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
63. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
64. R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, 2015).
65. Oksanen, J. et al. vegan: Community Ecology. R package version 2.4-2 http://CRAN.R-project.org/package=vegan (2017).
66. McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).
67. Gloor, G. B. & Reid, G. Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data. Can. J. Microbiol. 62, 692–703 (2016).
68. Fletcher, T. D. QuantPsyc: Quantitative Psychology Tools. R package version 1.5 http://cran.r-project.org/package=QuantPsyc (2012).
69. Morgan, M. DirichletMultinomial: Dirichlet-Multinomial Mixture Model Machine Learning for Microbiome Data. Bioconductor version 1.20.0 http://bioconductor.org/packages/release/bioc/html/DirichletMultinomial.html (2017).
70. Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, New York, 2009).
71. Revell, L. J. phytools: an R package for phylogenetic comparative biology (and other things). Methods Ecol. Evol. 3, 217–223 (2012).
72. Wei, T. et al. corrplot: Visualization of a Correlation Matrix. R package version 0.77 http://CRAN.R-project.org/package=corrplot (2016).
73. Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 42, 459–471 (2014).
74. Kanehisa, M. et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42, D199–D205 (2014).
75. Vieira-Silva, S. et al. Species–function relationships shape ecological properties of the human gut microbiome. Nat. Microbiol. 1, 16088 (2016).
76. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457–D462 (2016).
77. Haft, D. H. et al. TIGRFAMs and genome properties in 2013. Nucleic Acids Res. 41, D387–D395 (2013).
78. Powell, S. et al. eggNOG v3.0: orthologous groups covering 1133 organisms at 41 different taxonomic ranges. Nucleic Acids Res. 40, D284–D289 (2012).
79. Cheng, F. et al. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J. Chem. Inf. Model. 52, 3099–3105 (2012).
80. Federhen, S. The NCBI Taxonomy database. Nucleic Acids Res. 40, D136–D143 (2012).
81. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, 590–596 (2013).
82. Asnicar, F., Weingart, G., Tickle, T. L., Huttenhower, C. & Segata, N. Compact graphical representation of phylogenetic data and metadata with GraPhlAn. PeerJ 3, e1029 (2015).